Tenth Consecutive Quarter of Revenue Growth

Recurring Service Revenue Expands to 65% of Total Revenue in Fourth Quarter
Provides 2015 Financial Guidance

NASHUA, N.H. (February 24, 2015) – iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of
advanced image analysis, workflow solutions and radiation therapy for the early identification and
treatment of cancer, today reported financial results for the three months and fiscal year ended December
31, 2014.

Full Results